ann richmond
Vanderbilt University
H-index: 78
North America-United States
Top articles of ann richmond
Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy
ACS nano
2024/4/23
Abstract LB082: A high-throughput immune-oncology screen identifies immunostimulatory properties of low dose chemotherapy in triple negative breast cancer
Cancer Research
2024/4/5
Joshua Bauer
H-Index: 20
Ann Richmond
H-Index: 37
Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC
Cancer Letters
2024/2/3
Harnessing the Potential of CD40 Agonism in Cancer Therapy
2023/12/4
Time-restricted feeding and Alzheimer’s disease: you are when you eat
2023/10/21
CXCR2 chemokine receptor–a master regulator in cancer and physiology
2023/10/21
Ann Richmond
H-Index: 37
Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma
Cancers
2023/7/20
Chi Yan
H-Index: 1
Ann Richmond
H-Index: 37
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth
Molecular Cancer
2023/6/3
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy (vol 113, pg 1285, 2021)
JNCI: Journal of the National Cancer Institute
2021/10/1
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Journal for ImmunoTherapy of Cancer
2023
A Nanoparticle RIG-I Agonist for Cancer Immunotherapy
bioRxiv
2023
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis
Cell reports
2022/12/20
Amrendra Kumar
H-Index: 0
Ann Richmond
H-Index: 37
Correction: A novel NF-κB-inducing kinase-MAPK signaling pathway up-regulates NF-κB activity in melanoma cells
Journal of Biological Chemistry
2022/8/1
Ann Richmond
H-Index: 37
Loss of vascular endothelial glutaminase inhibits tumor growth and metastasis, and increases sensitivity to chemotherapy
Cancer research communications
2022/7/21
Immunomodulatory properties of PI3K/AKT/mTOR and MAPK/MEK/ERK inhibition augment response to immune checkpoint blockade in melanoma and triple-negative breast cancer
2022/7/1
Ann Richmond
H-Index: 37
Chi Yan
H-Index: 1
Close proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients
The Journal of Immunology
2022/5/1
Chi Yan
H-Index: 1
Ann Richmond
H-Index: 37
Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study
British Journal of Ophthalmology
2022/2/1
Ann Richmond
H-Index: 37
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients
NPJ Precision Oncology
2022/1/20
Chi Yan
H-Index: 1
Ann Richmond
H-Index: 37
The Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP): History and Highlights of 20 Years of Accomplishments
Journal of health care for the poor and underserved
2022
Ann Richmond
H-Index: 37
Venkataswarup Tiriveedhi
H-Index: 22
The role of PI3K inhibition in the treatment of breast cancer, alone or combined with immune checkpoint inhibitors
2021/5/7
Ann Richmond
H-Index: 37
Co-Authors
